Dawn Holt
Impact in
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects
- Microbial Natural Products and Biosynthesis
- Biotechnology top 5%
- Microbial Metabolism and Applications
Papers in
-
- Inflammatory mediators and NSAID effects 7
- Genetics 5
- Estrogen and related hormone effects 5
- Co-authors
- Amy M. Fulton (9 shared papers)Namita Kundu (8 shared papers)Xinrong Ma (8 shared papers)Jocelyn Reader (3 shared papers)Olga Goloubeva (4 shared papers)Paul R. August (2 shared papers)I A MacNeil (2 shared papers)Marcia S. Osburne (2 shared papers)
- Journals
- Cancer Research (2 papers)Journal of Immunotherapy (1 paper)Breast Cancer Research and Treatment (1 paper)Anti-Cancer Drugs (1 paper)OncoImmunology (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Dawn Holt
12 papers receiving 886 citations
Peers
Comparison fields: 5 of 97
- Pharmacology 270
- Biotechnology 119
- Immunology 244
- Oncology 262
- Psychiatry and Mental health 89
Countries citing papers authored by Dawn Holt
This map shows the geographic impact of Dawn Holt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn Holt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn Holt more than expected).
Fields of papers citing papers by Dawn Holt
This network shows the impact of papers produced by Dawn Holt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn Holt. The network helps show where Dawn Holt may publish in the future.
Co-authors
The 25 scholars most cited alongside Dawn Holt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Expression and isolation of antimicrobial small molecules from soil DNA libraries. | 2001 | 144 |
| 2 | 2011 | 137 | |
| 3 | 2011 | 131 | |
| 4 | 2009 | 126 | |
| 5 | Sequence analysis and functional characterization of the violacein biosynthetic pathway from Chromobacterium violaceum. | 2000 | 116 |
| 6 | 2013 | 84 | |
| 7 | 2012 | 70 | |
| 8 | 2008 | 53 | |
| 9 | 2011 | 45 | |
| 10 | Targeting the EP4 receptor for prostaglandin E2 increases natural killer cell lytic activity and inhibits metastasis | 2007 | 5 |
| 11 | 2013 | 2 | |
| 12 | Production and secretion of endothelin 1 in colorectal cancer | 1997 | 1 |
About Dawn Holt
Dawn Holt is a scholar working on Pharmacology, Genetics, Organic Chemistry, Oncology and Psychiatry and Mental health, having authored 12 papers that have together received 914 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (7 papers), Estrogen and related hormone effects (5 papers), Chemokine receptors and signaling (3 papers), Cancer, Stress, Anesthesia, and Immune Response (3 papers), Synthesis and Biological Evaluation (3 papers), Echinoderm biology and ecology (1 paper), Immunotherapy and Immune Responses (1 paper) and T-cell and B-cell Immunology (1 paper). The work is most often cited by research in Pharmacology (270 citations), Biotechnology (119 citations), Immunology (244 citations), Oncology (262 citations) and Psychiatry and Mental health (89 citations). Dawn Holt has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Amy M. Fulton, Namita Kundu, Xinrong Ma, Jocelyn Reader, Olga Goloubeva, Paul R. August, I A MacNeil, Marcia S. Osburne, Peter D. Collin and Michael Lipsky. Their work appears in journals such as Cancer Research, Journal of Immunotherapy, Breast Cancer Research and Treatment, Anti-Cancer Drugs and OncoImmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.